Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
Key facts
- Who runs it
- CMH Kharian Medical College
- Where
- Kharan, PakistanSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 5 May 2025
- Planned end
- 30 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Magnesium glycinate
- Melatonin
- Record updated
- 30 May 2025
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age 18-40 years
- Gender: Male and Females (Non-pregnant \& Non lactating)
- Diagnosed cases of primary insomnia according to following criteria:; Difficulty falling asleep, staying asleep or nonrestorative sleep; This difficulty is present despite adequate opportunity \& circumstance to sleep; This impairment in sleep is associated with daytime impairment or distress; This sleep difficulty occurs at least 3 times per week and has been a problem for at least 1 month
Who cannot take part
- Any psychiatric illness
- Insomnia due to a known underlying cause
- Active use of sedative hypnotics
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Where in Pakistan
- CMH Kharian Medical CollegeKharan, PakistanContact: Mushayada Irshad, MBBS, MphilTaking people
About the trial
What the trial wants to find out
Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.
The 2 groups in the trial
- Group ATreatment being tested
Group A will receive magnesium supplements for 4 weeks (Oral, Tablet, Dose 500mg/day at night)
Treatment: Magnesium glycinate
- Group BExisting treatment, for comparison
Group B will receive melatonin congener for 4 weeks (Oral, Tablet, Dose 10mg/day at night)
Treatment: Melatonin
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Fit questions
- Built from NCT06996171, who can take part
- Record updated
- 30 May 2025